https://en.e-cspc.com/ 2022-09-30 monthly 0.9 https://en.e-cspc.com/media/contact-us/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/about-us/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/about-us/who-are-we/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/our-history/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/our-members/cspc-nbp-pharmaceutical-co-ltd.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/about-us/governance-and-leadership/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/science/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/science/r-d/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/science/r-d/global-research-system/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/r-d-platform/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/healthcare-pipelines/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/science/r-d/clinical-trials/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/science/r-d/communication-and-cooperation/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/solutions/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/core-product/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/formulation/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/azithromycin/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/penem-preparations/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/penicillin-powder-for-injection/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/penicillin-oral-solid-product/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/cephalosporin-injection/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/other-products/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/products/quality-assurance/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/sustainability/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/sustainability/compliance-and-ethics/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/sustainability/environmental-protection/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/sustainability/healthy-development-of-employees/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/sustainability/support-for-the-communities/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/investors/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/media/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/stories/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/innovation/innovative-development-strategy.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/cspc-again-ranked-in-brand-finance-china-500.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/cspc-selected-as-china-s-top-10-innovative-bigpharma-companies.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/cspc-selected-as-one-of-top-100-chinese-pharmaceutical-innovative-enterprises-2022.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/legal-terms/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/privacy-protection/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/cephalosporin-injection/cephalosporins-injection.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/azithromycin/azithromycin.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/solutions/oncology.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/solutions/digestion.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/solutions/psychiatry.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/solutions/immune.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/solutions/cardiovascular-system.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/solutions/anti-infection.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/lenalidomide-capsules-obtains-drug-registration-approval.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/tg103-injection-obtains-clinical-trial-approval-for-the-treatment-of-non-alcoholic-steatohepatitis.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/tg103-injection-obtains-clinical-trial-approval-for-the-treatment-of-alzheimers-disease.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/index_2.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/penem-preparations/meropenem.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/penicillin-powder-for-injection/penicillins-powder-for-injection.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/levamlodipine-maleate-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/metformin-hydrochloride-extended-release-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/metformin-hydrochloride-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/azithromycin-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/tramadol-hydrochloride-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/carbamazepine-extended-release-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/paliperidone-extended-release-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/gabapentin-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/gabapentin-capsules.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/celecoxib-capsules.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/paroxetine-extended-release-tablets.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/esomeprazole-delayed-release-capsules.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/nda-and-anda-preparation/benzonatate-capsules.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/vitamin-c-series.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/vitamin-b12-series.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/caffeine-series.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/dextrose-anhydrous.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/acarbose.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/penicillin-series.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/cephalosporin-series.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/carbapenems.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/api/macrolides.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/media/index_2.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/media/index_3.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/media/index_4.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/our-members/cspc-ouyi-pharmaceutical-co-ltd.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/our-members/cspc-zhongnuo-pharmaceutical-shijiazhuang-coltd.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/our-members/cspc-weisheng-pharmaceutical-shijiazhuang-co-ltd.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/our-members/hebei-huarong-pharmaceutical-co-ltd.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/our-members/cspc-innovation-pharmaceutical-co-ltd.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/our-members/cspc-shengxue-glucose-co-ltd.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/penicillin-oral-solid-product/penicillins-oral-solid-product.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/moxifloxacin-hydrochloride-and-sodium-chloride-injection-obtains-drug-registration-approval.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/class-1-new-drug-prusogliptin-tablets-meets-predefined-endpoints-in-the-pivotal-clinical-trials.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/selective-ntrk-and-ros1-dual-inhibitor-syhx2009-obtains-clinical-trial-approval.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/congratulations-on-the-successful-approval.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/cspc-advances-to-the-25th-place-in-the-pharma-1000-list.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/news/cspc-s-covid-19-vaccine-approved-for-clinical-trials.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/other-products/other-products.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/other-products/39.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/lab/alamab-therapeutics-innovative-first-inclass.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/patient/his-story-with-mitoxantrone-hydrochloride-liposome-injection.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/lab/cspc-open-day-showcases-innovation-achievements.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/manufacturing-plant/six-women-volunteers-of-cspc-in-huo-yan-air-lab.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/manufacturing-plant/anvisa-declares-two-cspc-products-exempt-from-inspection.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/manufacturing-plant/a-special-inspection.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/patient/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/manufacturing-plant/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/transparency/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/transparency/esmo-focus-duoenda-s-research-findings-selected-for-oral-session.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/transparency/esmo-focus-the-latest-research-findings-of-doxorubicin-unveiled.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/transparency/latest-clinical-study-of-keaili-in-gastric-cancer-treatment-was-released.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/lab/passion-and-persistence:-a-new-departure-after-opdivo.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/stories/index_2.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/transparency/SYS6006_mRNA_vaccine.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/lab/ 2022-09-29 monthly 0.8 https://en.e-cspc.com/transparency/The-study-of-Jinyouli-selected-for-presentation-at-ASCO.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/transparency/2.html 2022-09-29 monthly 0.8 https://en.e-cspc.com/transparency/New-Study-of-Duomeisu-on-Breast-Cancer.html 2022-09-29 monthly 0.8